Clinical Trials Browser

Phase 2 × Locally Advanced Rectal Cancer (LARC) × 30 days × Clear all

NCT06933251 2026-03-09

PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Locally Advanced Rectal Cancer (LARC)